General Information

Penumbra is a global interventional therapies company that designs, develops, manufactures and markets innovative medical devices. We have a broad portfolio of products that addresses challenging medical conditions and significant clinical needs across two major markets, neuro and peripheral vascular. The conditions that our products address include, among others, ischemic stroke, hemorrhagic stroke and various peripheral vascular conditions that can be treated through thrombectomy and embolization procedures.

Employees: 1000
Founded: 2004
Contact Information
Address One Penumbra Place, 1351 Harbor Bay Parkway, Alameda, CA 94502, US
Phone Number (510) 748-3200
Web Address
View Prospectus: Penumbra
Financial Information
Market Cap $901.2mil
Revenues $149.1 mil (last 12 months)
Net Income $-1.2 mil (last 12 months)
IPO Profile
Symbol PEN
Exchange NYSE
Shares (millions): 4.0
Price range $30.00 - $30.00
Est. $ Volume $120.0 mil
Manager / Joint Managers J.P. Morgan/ BofA Merrill Lynch
CO-Managers Wells Fargo Securities/ Canaccord Genuity
Expected To Trade: 9/18/2015
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change